Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Published in: European Journal of Clinical Microbiology & Infectious Diseases 8/2007

01-08-2007 | Brief Report

Multidrug-resistant tuberculosis in the Czech Republic: strategy and therapeutic outcomes

Author: V. Bartu

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 8/2007

Login to get access

Excerpt

The Czech Republic is situated in the center of Europe and it has a low incidence of tuberculosis (TB). The number of reported TB cases has declined continuously in recent years, from 1,442 (14 per 100,000 population) in 2000 to 1,006 (9.9 per 100,000 population) in 2004. The incidence of multidrug-resistant tuberculosis (MDR TB) is about 2% of all TB cases, and it has remained constant for several years. The goal of the present study was to evaluate the outcome of patients with MDR TB who were hospitalized in the Central MDR TB Unit at Charles University and Thomayer University Hospital in Prague and treated with individualized regimens in accordance with the results of drug susceptibility tests. …
Literature
1.
Espinal MA, Laszlo A, Simonsen E et al (2001) Global trends in resistance to antituberculosis drugs. N Engl J Med 344:1294–1303PubMedCrossRef
2.
3.
Sbarbaro JA (1997) Multidrug-resistant tuberculosis. It is time to focus on the private sector of medicine. Chest 111:1149–1151PubMed
4.
World Health Organization (2004) Treatment of tuberculosis: guidelines for national programmes, 3rd edn. WHO, Geneva, Switzerland, Publication WHO/CDS/TB/2003.313
5.
Caminero JA (2005) Management of multidrug-resistant tuberculosis and patients in retreatment. Eur Respir J 25:928–936PubMedCrossRef
6.
van Rie A, Victor TC, Richardson M (2005) Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns. Am J Respir Care Med 172:636–642CrossRef
7.
Mitnick C, Byona J, Palacois E et al (2003) Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med 348:119–128PubMedCrossRef
8.
9.
Mohapatra PR (2004) Fluoroquinolones in multidrug-resistant tuberculosis. Am J Respir Crit Care Med 169:920–921
Metadata
Title
Multidrug-resistant tuberculosis in the Czech Republic: strategy and therapeutic outcomes
Author
V. Bartu
Publication date
01-08-2007
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 8/2007
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-007-0332-2

Other articles of this Issue 8/2007

European Journal of Clinical Microbiology & Infectious Diseases 8/2007 Go to the issue

Article

Extended-spectrum beta-lactamase-producing Klebsiella spp. in a neonatal intensive care unit: risk factors for the infection and the dynamics of the molecular epidemiology

Article

Fungemia at a tertiary care hospital: incidence, therapy, and distribution and antifungal susceptibility of causative species

Article

Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries

Article

Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study

Article

Sources and outcome of bloodstream infections in cancer patients: the role of central venous catheters

Concise Article

Evaluation and comparison of two stuart’s liquid swab transport systems tested by the CLSI M40 method
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits